[2S10m-05] Development of novel therapeutic agents for HTLV-1 infectious disease targeting endoplasmic reticulum stress response

^○Emi Ikebe¹, Sahoko Matsuoka¹, Kenta Tezuka¹, Madoka Kuramitsu¹, Kazu Okuma¹, Makoto Nakashima², Seiichiro Kobayashi³, Junya Makiyama⁴, Makoto Yamagishi², Seiichi Oyadomari⁵, Kaoru Uchimaru^2,4, isao Hamaguchi¹ (1.Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan, 2.Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan, 3.Division of Molecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 4.Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Japan, 5.Division of Molecular Biology, Institute of Advanced Medical Science, Tokushima University, Tokushima, Japan)

キーテクノロジー：オミクス解析

小胞体ストレス、アポトーシス、HTLV-1、ATL